Laura and Isaac Perlmutter Cancer Center NYU Langone Health is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Laura and Isaac Perlmutter Cancer Center NYU Langone Health has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck.
Sponsors: Janux Therapeutics.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Laura and Isaac Perlmutter Cancer Center NYU Langone Health has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Laura and Isaac Perlmutter Cancer Center NYU Langone Health has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck.
Laura and Isaac Perlmutter Cancer Center NYU Langone Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.